A phase 2 study of alrizomadlin, a novel MDM2/p53 inhibitor, in combination with pembrolizumab for treatment of patients with malignant peripheral nerve sheath tumor (MPNST). This is an ASCO Meeting ...
A transjugular intrahepatic portosystemic shunt (TIPS for short) is a procedure meant to help blood flow more easily through your liver. It’s usually done to treat complications caused by liver damage ...
The progressive worsening of liver cirrhosis and portal hypertension (HTN) decreases intra-hepatic nitric oxide (NO), which is counterbalanced by increased NO secretion from adjacent endothelial cells ...
Xarelto improved portal hypertension complication-free survival in patients with cirrhosis and moderate liver dysfunction without an increase in major bleeding events, according to data presented at ...
Liver regeneration after radiotherapy in patients with hepatocellular carcinoma: A simple-to-use model and nomogram. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This abstract ...
The suggested approach for the management of patients with compensated advanced chronic liver disease. Abbreviations: cACLD, compensated advanced chronic liver disease; CSPH, clinically significant ...
Spleen stiffness measurement could revolutionize the diagnosis and management of portal hypertension
Portal hypertension (PHT) is a severe complication of chronic liver disease, like cirrhosis, where increased pressure builds up in the portal vein. This major blood vessel drains blood from the ...
Ascites is a common complication of cirrhosis. It happens due to the effects of portal hypertension and leads to fluid buildup in your abdomen. Ascites can be treated with medications, procedures, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback